Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
GLS protein | 1 | 0 | 0 | 1 |
GLI family zinc finger 3 | 1 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
retinoic acid nuclear receptor alpha variant 1 | 2 | 0 | 0 | 2 |
farnesoid X nuclear receptor | 3 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 1 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
geminin | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Spike glycoprotein | 2 | 0 | 0 | 2 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
Efflux transporter | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Class D beta-lactamase | 0 | 1 | 0 | 2 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
Metallo-b-lactamase | 0 | 0 | 0 | 2 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 1 | 0 | 2 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 2 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
Stimulator of interferon genes protein | 0 | 0 | 1 | 1 |
Stimulator of interferon genes protein | 0 | 0 | 2 | 2 |
RocR | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 4 | 0 | 1 | 0 | 2 |
Multidrug resistance-associated protein 5 | 0 | 0 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 2 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 2 |
Delta-type opioid receptor | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 3 |
Cholinesterase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
AR protein | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
progesterone receptor | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
estrogen nuclear receptor alpha | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
activating transcription factor 6 | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Beta-lactamase OXA-1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Beta-lactamase TEM | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
RAR-related orphan receptor gamma | 1 | 0 | 0 | 1 |
USP1 protein, partial | 1 | 0 | 0 | 1 |
TDP1 protein | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
pregnane X nuclear receptor | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
Histone H2A.x | 1 | 0 | 0 | 1 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Interferon beta | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Squalene monooxygenase | 0 | 1 | 0 | 1 |
Squalene monooxygenase | 0 | 2 | 0 | 2 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |